Tuesday, 04 Nov 2025

Nxera unveils proprietary pipeline targeting obesity and metabolic disorders

Written by
PharmaTimes
Published
New oral GLP-1 agonist aims to reshape chronic weight management New oral GLP-1 agonist aims to reshape chronic weight management
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago